Your browser doesn't support javascript.
loading
Delineating the interactions between the cannabinoid CB2 receptor and its regulatory effectors; ß-arrestins and GPCR kinases.
Patel, Monica; Matti, Christoph; Grimsey, Natasha L; Legler, Daniel F; Javitch, Jonathan A; Finlay, David B; Glass, Michelle.
Affiliation
  • Patel M; Department of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
  • Matti C; Department of Biology, Biotechnology Institute Thurgau (BITg) at the University of Konstanz, Kreuzlingen, Switzerland.
  • Grimsey NL; Department of Pharmacology and Clinical Pharmacology, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
  • Legler DF; Department of Biology, Biotechnology Institute Thurgau (BITg) at the University of Konstanz, Kreuzlingen, Switzerland.
  • Javitch JA; Faculty of Biology, University of Konstanz, Konstanz, Germany.
  • Finlay DB; Theodor Kocher Institute, University of Bern, Bern, Switzerland.
  • Glass M; Department of Psychiatry and Pharmacology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Br J Pharmacol ; 179(10): 2223-2239, 2022 05.
Article in En | MEDLINE | ID: mdl-34811740

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cannabinoids / Receptor, Cannabinoid, CB2 / G-Protein-Coupled Receptor Kinases / Beta-Arrestin 2 Limits: Humans Language: En Journal: Br J Pharmacol Year: 2022 Document type: Article Affiliation country: New Zealand Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cannabinoids / Receptor, Cannabinoid, CB2 / G-Protein-Coupled Receptor Kinases / Beta-Arrestin 2 Limits: Humans Language: En Journal: Br J Pharmacol Year: 2022 Document type: Article Affiliation country: New Zealand Country of publication: United kingdom